DCC Vital – a leading provider of medical products, pharmaceuticals, medical devices, logistics and GP supplies – are joining the ABHI UK Pavilion for the first time at Arab Health 2022 (24 – 27 January 2022) to showcase their new range of eye protectors offering patients enhanced eye protection during general anaesthesia, as well as their wide range of innovative Endoscopic and Theatre products.   

The new iPRO Elite Silicone is a single-use eye protector which is applied to a patient’s eye during induced anaesthesia, helping the orbital area to remain in its pre-surgery condition.  The novel device is designed to offer several advantages over traditional tape and acrylic eye protectors, reducing the risk of corneal abrasion, contamination and skin tears.

Over 2.7 million patients in the UK have surgery under general anaesthesia per year.[1] Patients undergoing surgery under general anaesthesia can develop ocular complications, the most common of which is a corneal abrasion, which is costly to treat and very painful for the patient.

Corneal abrasions can usually be prevented by careful protection of the eyes. Common practice is to tape the patient’s eyelids closed using a roll of surgical tape with an acrylic adhesive. However, this can cause skin abrasion, increasing the risk of post-surgery infection. Medical adhesive products have also been documented as a source of potential infection. A 2010 independent lab study revealed that MRSA and/or VRE were found on over 50% of 21 rolls tested, with at least three rolls testing positive for both.[2]

Clinical studies have also found that older populations (65 and over) are more susceptible to skin injuries caused by medical tape.[3] With a growing elderly population and advancing surgical procedures increasing in complexity and duration, minimising skin trauma when removing eye care products is essential. The silicone IPRO ELITE has been designed to meet these needs, especially among patients with fragile or at-risk skin.[4]

Joseph Coogan, Product Development Manager at DCC Vital said: “Anaesthetists have to take great care to ensure the eyes are closed during a general anaesthetic to protect a patient’s eyes. This is important to prevent the risks of corneal abrasion, skin damage and infection, particularly as research shows that approximately 6 out of 10 people do not close their eyes naturally when they have a general anaesthetic. Our new IPRO ELITE protectors are designed with a unique silicone adhesive to offer patients enhanced safety and protection. We are delighted to be joining the ABHI UK Pavilion at Arab Health 2022 to showcase how it can support patients and clinicians globally.”

Unlike other eye protectors, DCC Vital’s IPRO ELITE protectors are made from a unique combination of a protective film and a gentle silicone adhesive (patent pending) that is non-porous, making it resistant to bacterial contamination. Silicone has also been shown to be very gentle to the skin[5] with greater patient satisfaction when used as an alternative to standard adhesive tapes[6]. In addition, the material has a lower surface tension and requires only a gentle force for removal[7] carrying significantly less risk of skin injury and resulting in a lower incidence of skin trauma.[8]

For patients, the use of a mild adhesive significantly reduces the likelihood of impact on the skin while also helping to keep the eye closed during surgery to reduce the risk of corneal abrasion. The use of a non-adhesive tab further allows the clinician to remove and alter the positioning of the protector easily, while the transparent design of the device allows continued monitoring of the eye and orbital area during surgery.

Paul Benton, Managing Director, International at the ABHI added: “We are delighted that DCC Vital have chosen to launch their new range of eye protectors for patients undergoing surgery on the ABHI UK Pavilion. The company is committed to developing innovations that support enhanced patient safety, and we look forward to supporting them at Arab Health 2022.”

Arab Health 2022 is taking place from 24 – 27 January 2022 at the Dubai World Trade Centre. Throughout the show, DCC Vital will be located on the ABHI UK Pavilion – H2, G35.

For more information, visit https://www.dccvital.com/.



[1] BJA: British Journal of Anaesthesia, Volume 113, Issue 4, 1 October 2014, Pages 575–584
[2] Harris, P. et al. 2012 Adhesive Tape in the Health Care Setting: Another High-Risk Fomite? Medical Journal of Australia vol. 196(1), pp. 34.
[3] Konya, C. et al. 2010. Skin injuries caused by medical adhesive tape in older people and associated factors. Journal of Clinical Nursing. vol 19, pp. 1236-42
[4] Manriquez, S. et al. 2014. Evaluation of a new silicone adhesive tape among clinicians caring for patients with fragile or at-risk skin. Advanced Skin Wound Care. 27(4):163-70.
[5] McNichol, L. et al. 2013. Medical Adhesives and Patient Safety: State of the Science: Consensus statements for the assessment, prevention, and treatment of adhesive-related skin injuries. Journal of Wound Ostomy and Continence Nursing vol 40(4), pp. 365-80
[6] Zeng, L. et al. 2016. Comparison of Medical Adhesive Tapes in Patients at Risk of Facial Skin Trauma under Anesthesia. Anesthesiology Research and Practice. Vol 2016: 4878246.
[7] Kim, T. et al. 2018. Medical adhesive related skin injury after dental surgery. Journal of Dental Anesthesia and Pain Medicine. 18(5): pp. 305-308
[8] Chuang, T. et al. 2006. Inadvertent Eyelid Irritant Contact Dermatitis from Hypoallergenic Surgical Tape.” Chang Gung Medical Journal. Vol. 29 (4) (Suppl) pp. 25-27

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2022

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.